BioElectronics Corporation ACTIPATCH
Winning Technology: ActiPatch (Pulsed Shortwave Therapy) Orthopedics This Week Publication
Inventor: John Martinez
Engineers: John Martinez, Sree Koneru, Ph.D.
John Martinez, Iqra Anwar-Deen, Sree N. Koneru, Ph.D., and ActiPatch
ActiPatch device is a wearable, low-power, pulsed shortwave therapy device for adjunctive treatment of osteoarthritis of the knee and plantar fasciitis. ActiPatch emits a low level, pulsed electromagnetic energy field over the treatment site at a frequency in the 27.1 MHz ISM band and is pulsed-modulated at 1 KHz with a duty cycle of 10%. The battery supplies power for 720 hours.
The high-frequency, low-power nature of the stimulus means that users experience no sensations of any kind. Chronic pain results from the process of sensitization of the underlying nerves, which most often occurs when high levels of acute pain are sustained for an extended time-period. When sustained tissue insult or injury sensitizes the central nervous system even non-painful stimuli can produce painful responses. This process occurs in the spine of the individual, which is considered part of the central nervous system, and so is referred to as “central sensitization.” Central sensitization is associated with a wide variety of pain conditions, including osteoarthritis of the knee pain, neck pain, low back pain, dysmenorrhea, fibromyalgia, myofascial pain, migraines and painful bladder, among many others. Providing continuous, new information to peripheral nerves is key to mitigating central sensitization, and this is accomplished by the ActiPatch.
